Skip to content
  • Sunday, 26 July 2026
  • 3:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Study: Toxic Exposure in Pregnancy May Drive Disease Risk Across Generations
Clinical Diagnostics & Pathology

Study: Toxic Exposure in Pregnancy May Drive Disease Risk Across Generations

Reynand Amr Wu Apr 29, 2026 0

A groundbreaking study from Washington State University (WSU) has unveiled startling evidence suggesting that a singular exposure to a common…

Read More
Clinical Diagnostics & Pathology

Study: Toxic Exposure in Pregnancy May Drive Disease Risk Across Generations

Reynand Amr Wu Apr 22, 2026 0

A groundbreaking study conducted by Washington State University (WSU) and published in the prestigious Proceedings of the National Academy of…

Read More
Clinical Diagnostics & Pathology

A Single Prenatal Toxic Exposure Linked to Multi-Generational Disease Risk, Paving Way for Epigenetic Diagnostics

Reynand Amr Wu Apr 14, 2026 0

New research emerging from Washington State University (WSU) has unveiled a groundbreaking understanding of disease inheritance, suggesting that a singular…

Read More
Clinical Diagnostics & Pathology

Study: Toxic Exposure in Pregnancy May Drive Disease Risk Across Generations

Reynand Amr Wu Apr 6, 2026 0

A groundbreaking study conducted by researchers at Washington State University (WSU) has unveiled a profound and concerning mechanism through which…

Read More
Neuroscience & Brain Research

Long-Term Residential Exposure to Chlorpyrifos Linked to Significant Increase in Parkinson’s Disease Risk According to New UCLA Health Study

Rifan Muazin Apr 5, 2026 0

A comprehensive study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
Advanced Materials Science

UC Davis Researchers Uncover Reversible Shape-Changing Properties in Perovskite Crystals Under Light Exposure

Nila Kartika Wati Apr 2, 2026 0

A multidisciplinary team of researchers at the University of California, Davis, has documented a significant physical phenomenon in a class…

Read More
Neuroscience & Brain Research

Long-Term Residential Exposure to Chlorpyrifos Increases Parkinson’s Disease Risk by Over Two and a Half Times UCLA Health Study Finds

Rifan Muazin Mar 27, 2026 0

A groundbreaking longitudinal study conducted by researchers at UCLA Health has established a definitive link between chronic residential exposure to…

Read More
Neuroscience & Brain Research

Long-Term Exposure to Chlorpyrifos Linked to Significantly Higher Risk of Parkinson’s Disease According to UCLA Health Study

Rifan Muazin Mar 19, 2026 0

A comprehensive study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More

Posts pagination

1 2
US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved DrugsScience News: A Century of Empowering Public Understanding of ScienceUnraveling the Tangled Genetic Tapestry of Our Most Vital CropsA Novel DNA Test Revolutionizes Root Biomass Quantification and Unlocks Deeper Insights into Plant Carbon Storage
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ